タンパク質工学市場：製品タイプ、製品・サービス、技術、エンドユーザー別-2025-2030年の世界予測

タンパク質工学市場は、2023年に37億9,000万米ドルと評価され、2024年には41億6,000万米ドルに達すると予測され、CAGR 10.21％で成長し、2030年には74億9,000万米ドルになると予測されています。

タンパク質工学はバイオテクノロジーの中でもダイナミックな分野であり、タンパク質の構造を改変して所望の特性を実現することで、さまざまな用途に大きな可能性を提供します。その範囲は、医薬品、農業、工業プロセスへの応用のために、機能性を強化し、安定性を向上させ、有効性を高めた新規タンパク質を設計することを包含します。タンパク質工学の必要性は、より効果的な治療法、持続可能な農業ソリューション、環境に優しい工業用酵素に対する需要の高まりから生じています。主な用途としては、標的疾患治療用モノクローナル抗体の開発、バイオ燃料生産用酵素、作物の耐性形質などがあります。最終用途産業は、バイオテクノロジーや医薬品から農業や化学製造分野まで幅広いです。

タンパク質工学の市場成長は、バイオ医薬品研究開発への投資の増加と個別化医療への需要の高まりに大きく影響されています。バイオ研究を支援する政府の取り組みや、タンパク質欠乏症関連疾患の増加が市場拡大をさらに後押ししています。しかし、この分野は、研究開発に伴う高コスト、タンパク質設計の技術的複雑さ、厳しい規制要件などの課題に直面しています。こうしたハードルにもかかわらず、潜在的なビジネスチャンスは、タンパク質設計の精度とスピードを高めるAIと機械学習技術の台頭にあります。企業は競争力を維持し、イノベーションを促進するために、これらの技術の導入に注力すべきです。

こうした機会を活用するため、企業は学術機関やハイテク企業との提携や協力に投資し、最先端の計算ツールを活用すべきです。バイオ医薬品の需要が高まり、医療費支出が増加している新興市場は、事業拡大の有望な分野です。イノベーションのプロセスを合理化するためには、知的財産の問題や高度な専門知識を必要とするなどの制約に対処する必要があります。市場競争は激しいが、技術の進歩を受け入れる企業には大きな成長の可能性があります。持続可能な成長と競争力を確保するために、イノベーションは費用対効果の高いタンパク質修飾技術の開発と人工タンパク質の応用範囲の拡大に焦点を当てるべきです。

市場力学：急速に進化するタンパク質工学市場の主要市場インサイトを公開

タンパク質工学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 非タンパク質医薬品よりもタンパク質治療薬への嗜好の高まり
  • タンパク質ベースの医薬品採用の増加
  • 生活習慣病および慢性疾患の有病率の上昇
  • 化学プロセスに代わるものへの需要の増加
• 市場抑制要因
  • プロセスを戦略化するための訓練された人材の不足
• 市場機会
  • タンパク質工学に対する政府資金の増加
  • タンパク質工学における生物科学の急速な発展
• 市場の課題
  • タンパク質工学における高価な機器の莫大な維持費

ポーターの5つの力：タンパク質工学市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、タンパク質工学市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：タンパク質工学市場における外部からの影響の把握

外部マクロ環境要因は、タンパク質工学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析タンパク質工学市場における競合情勢の把握

タンパク質工学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスタンパク質工学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、タンパク質工学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨タンパク質工学市場における成功への道筋を描く

タンパク質工学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 非タンパク質医薬品よりもタンパク質治療薬の好感度が高まっている
    • タンパク質ベースの医薬品の採用増加
    • 生活習慣病や慢性疾患の増加
    • 化学プロセスの代替品に対する需要の増加
  • 抑制要因
    • プロセスを戦略化するための訓練を受けた人材の不足
  • 機会
    • タンパク質工学に対する政府資金の増加
    • タンパク質工学の生物科学の急速な発展
  • 課題
    • タンパク質工学の高価な楽器の大規模なメンテナンス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 タンパク質工学市場：タイプ別

• 凝固因子
• コロニー刺激因子
• エリスロポエチン
• 成長ホルモン
• インスリン
• インターフェロン
• モノクローナル抗体
• ワクチン

第7章 タンパク質工学市場：製品・サービス別

• 消耗品
• 機器
• ソフトウェアとサービス

第8章 タンパク質工学市場：技術別

• 非合理的なタンパク質設計か、それとも指向性進化か
• 合理的なタンパク質設計

第9章 タンパク質工学市場：エンドユーザー別

• 学術調査機関
• バイオ医薬品企業
• 契約調査機関

第10章 南北アメリカのタンパク質工学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のタンパク質工学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのタンパク質工学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abzena, Ltd.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Codexis, Inc.
• Danaher Corporation
• Genscript Biotech Corporation
• Innovagen AB
• Merck KGaA
• New England Biolabs, Inc.
• Perkinelmer, Inc.
• Phynexus, Inc.
• Promega Corporation
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. PROTEIN ENGINEERING MARKET RESEARCH PROCESS
• FIGURE 2. PROTEIN ENGINEERING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTEIN ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PROTEIN ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PROTEIN ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTEIN ENGINEERING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTEIN ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEIN ENGINEERING MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COLONY-STIMULATING FACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY ERYTHROPOIETINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY IRRATIONAL PROTEIN DESIGN OR DIRECTED EVOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY RATIONAL PROTEIN DESIGN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CHINA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. CHINA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. ITALY PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. ITALY PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. POLAND PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. POLAND PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. QATAR PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. QATAR PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM PROTEIN ENGINEERING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM PROTEIN ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. PROTEIN ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. PROTEIN ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

The Protein Engineering Market was valued at USD 3.79 billion in 2023, expected to reach USD 4.16 billion in 2024, and is projected to grow at a CAGR of 10.21%, to USD 7.49 billion by 2030.

Protein engineering is a dynamic field within biotechnology that modifies protein structures to achieve desired characteristics, offering vast potential across various applications. Its scope encompasses designing novel proteins with enhanced functionalities, improved stability, and greater efficacy for applications in pharmaceuticals, agriculture, and industrial processes. The necessity for protein engineering arises from the growing demand for more effective therapies, sustainable agricultural solutions, and eco-friendly industrial enzymes. Key applications include the development of monoclonal antibodies for targeted disease treatment, enzymes for biofuel production, and resistance traits in crops. End-use industries broadly range from biotechnology and pharmaceuticals to agricultural and chemical manufacturing sectors.

Market growth in protein engineering is significantly influenced by the increasing investment in biopharmaceutical R&D and rising demand for personalized medicine. Government initiatives supporting biotech research and rising incidences of protein-deficiency-related diseases further propel market expansion. However, the field faces challenges such as high costs associated with research and development, technical complexities in protein design, and stringent regulatory requirements. Despite these hurdles, potential opportunities lie in the rise of AI and machine learning technologies, which enhance protein design precision and speed. Companies should focus on adopting these technologies to remain competitive and foster innovation.

To exploit these opportunities, businesses should invest in partnerships and collaborations with academic institutions and tech companies to leverage cutting-edge computational tools. Emerging markets, with a growing demand for biopharmaceuticals and increasing healthcare expenditure, provide promising areas for expansion. Limitations such as intellectual property issues and the high expertise required should be addressed to streamline innovation processes. The nature of the protein engineering market is highly competitive yet offers substantial growth potential for those who embrace technological advancements. Innovation should focus on developing cost-effective protein modification techniques and expanding the application range of engineered proteins to ensure sustainable growth and competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Engineering Market

The Protein Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing preference for protein therapeutics over non-protein drugs
  • Increasing adoption of protein-based drugs
  • Rising prevalence of lifestyle and chronic diseases
  • Increased demand for alternatives to chemical processes
• Market Restraints
  • Lack of trained personnel to strategize the process
• Market Opportunities
  • Rising government funding for protein engineering
  • Rapid development in biological science for protein engineering
• Market Challenges
  • Huge maintenance of the expensive instruments in protein engineering

Porter's Five Forces: A Strategic Tool for Navigating the Protein Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Engineering Market

A detailed market share analysis in the Protein Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Engineering Market

A strategic analysis of the Protein Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Engineering Market, highlighting leading vendors and their innovative profiles. These include Abzena, Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Codexis, Inc., Danaher Corporation, Genscript Biotech Corporation, Innovagen AB, Merck KGaA, New England Biolabs, Inc., Perkinelmer, Inc., Phynexus, Inc., Promega Corporation, Takara Bio, Inc., Thermo Fisher Scientific, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Protein Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Coagulation Factors, Colony-Stimulating Factors, Erythropoietins, Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, and Vaccines.
• Based on Product & Service, market is studied across Consumables, Instruments, and Software & Services.
• Based on Technology, market is studied across Irrational Protein Design or Directed Evolution and Rational Protein Design.
• Based on End-User, market is studied across Academic Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing preference for protein therapeutics over non-protein drugs
    • 5.1.1.2. Increasing adoption of protein-based drugs
    • 5.1.1.3. Rising prevalence of lifestyle and chronic diseases
    • 5.1.1.4. Increased demand for alternatives to chemical processes
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of trained personnel to strategize the process
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising government funding for protein engineering
    • 5.1.3.2. Rapid development in biological science for protein engineering
  • 5.1.4. Challenges
    • 5.1.4.1. Huge maintenance of the expensive instruments in protein engineering
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Engineering Market, by Type

• 6.1. Introduction
• 6.2. Coagulation Factors
• 6.3. Colony-Stimulating Factors
• 6.4. Erythropoietins
• 6.5. Growth Hormones
• 6.6. Insulin
• 6.7. Interferons
• 6.8. Monoclonal Antibodies
• 6.9. Vaccines

7. Protein Engineering Market, by Product & Service

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Instruments
• 7.4. Software & Services

8. Protein Engineering Market, by Technology

• 8.1. Introduction
• 8.2. Irrational Protein Design or Directed Evolution
• 8.3. Rational Protein Design

9. Protein Engineering Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Biopharmaceutical Companies
• 9.4. Contract Research Organizations

10. Americas Protein Engineering Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Protein Engineering Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Protein Engineering Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abzena, Ltd.
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Bruker Corporation
• 5. Codexis, Inc.
• 6. Danaher Corporation
• 7. Genscript Biotech Corporation
• 8. Innovagen AB
• 9. Merck KGaA
• 10. New England Biolabs, Inc.
• 11. Perkinelmer, Inc.
• 12. Phynexus, Inc.
• 13. Promega Corporation
• 14. Takara Bio, Inc.
• 15. Thermo Fisher Scientific, Inc.
• 16. Waters Corporation